Phio Pharmaceuticals PHIO
NASDAQ PHIO
$1.00 -0.03 (-2.89%)
At close: Oct 1, 2026 · 4:00 PM EDT

Phio Pharmaceuticals (PHIO) Accumulated Depreciation (2021 - 2025)

Updated

Phio Pharmaceuticals (PHIO) reported Accumulated Depreciation of $228,000 for Q4 2025, down 25.5% from $306,000 a year earlier.

Analysis

Phio Pharmaceuticals (PHIO) Accumulated Depreciation (2021 - 2025) Analysis & Trends

Dating back to Q4 2021, Phio Pharmaceuticals' Accumulated Depreciation record includes 5 quarters.

  • Accumulated Depreciation has declined for three consecutive years, with a four-year compound annual growth rate of -32.6% (FY2021 to FY2025).
  • By year, Accumulated Depreciation came in at $306,000 in FY2024 (-73.1%), $1.14 million in FY2023 (-3.3%), $1.18 million in FY2022 (+6.3%) and $1.11 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Phio Pharmaceuticals 11.97 Mn 11.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 228,000.00
Dec 31, 2024 306,000.00
Dec 31, 2023 1.14 Mn
Dec 31, 2022 1.18 Mn
Dec 31, 2021 1.11 Mn
API Access

Phio Pharmaceuticals Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=PHIO&period=max&api_key=YOUR_API_KEY